SPECTRIX THERAPEUTICS Trademark

Trademark Overview

On Tuesday, May 10, 2016, a trademark application was filed for SPECTRIX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SPECTRIX THERAPEUTICS trademark a serial number of 87031535. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, September 10, 2024. This trademark is owned by Spectrix Therapeutics, LLC. The SPECTRIX THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of pharmaceutical preparations for others; Research and development of technology in the field of pharmaceutical preparations for others
spectrix therapeutics

General Information

Serial Number87031535
Word MarkSPECTRIX THERAPEUTICS
Filing DateTuesday, May 10, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, September 10, 2024
Registration Number5424040
Registration DateTuesday, March 13, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2016

Trademark Statements

Amendment to a Registration/Renewal CertificateIn the statement, line 2, through line 4, is deleted, and "4451 Dale Earnhardt Way, Ste D14 Northlake,  TX 76262", is inserted.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesResearch and development in the field of pharmaceutical preparations for others; Research and development of technology in the field of pharmaceutical preparations for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 13, 2016
Primary Code042
First Use Anywhere DateThursday, September 21, 2017
First Use In Commerce DateThursday, September 21, 2017

Trademark Owner History

Party NameSpectrix Therapeutics, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNorthlake, TX 76262
Party NameSpectrix Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSouthlake, TX 76092
Party NameSpectrix Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSouthlake, TX 76092

Trademark Events

Event DateEvent Description
Thursday, December 28, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 9, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 10, 2024AMENDMENT UNDER SECTION 7 - PROCESSED
Friday, August 19, 2016EXAMINERS AMENDMENT -WRITTEN
Friday, June 9, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, December 13, 2017TEAS STATEMENT OF USE RECEIVED
Monday, February 5, 2024TEAS SECTION 7 REQUEST RECEIVED
Monday, February 5, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 19, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 10, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, May 13, 2016NEW APPLICATION ENTERED
Friday, May 13, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 18, 2016PUBLISHED FOR OPPOSITION
Wednesday, December 13, 2017USE AMENDMENT FILED
Tuesday, December 13, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 18, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 16, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 9, 2017SOU EXTENSION 1 FILED
Friday, June 9, 2017SOU EXTENSION 1 GRANTED
Friday, February 2, 2024TEAS SECTION 8 & 15 RECEIVED
Friday, August 19, 2016EXAMINERS AMENDMENT E-MAILED
Friday, August 19, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 13, 2018REGISTERED-PRINCIPAL REGISTER
Friday, August 19, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, September 28, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 10, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, March 13, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, September 12, 2016ASSIGNED TO LIE
Friday, August 19, 2016ASSIGNED TO EXAMINER
Wednesday, June 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 12, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 15, 2024NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

Related Keywords

therapeutics spectrix preparations others research pharmaceutical field development technology